Inactive Instrument

Redsense Medical AB (publ) Share Price Nasdaq Stockholm

Equities

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq Stockholm
- - Intraday chart for Redsense Medical AB (publ)

Financials

Sales 2022 16.75M 1.58M 0 125M Sales 2023 25.52M 2.41M 0 190M Capitalization 107M 10.07M 0 796M
Net income 2022 -8M -755K - -59.71M Net income 2023 -4M -378K - -29.85M EV / Sales 2022 7.31 x
Net cash position 2022 10.58M 999K 0 78.97M Net cash position 2023 6.97M 657K 0 51.99M EV / Sales 2023 3.91 x
P/E ratio 2022
-15.2 x
P/E ratio 2023
-23.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 100%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 31/12/22
Chief Operating Officer - 31/05/16
Chief Tech/Sci/R&D Officer - 31/12/19
Members of the board TitleAgeSince
Director/Board Member 53 31/12/12
Chairman 61 31/12/22
Director/Board Member - 31/12/22
More insiders
Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.
More about the company